Tuhi, Ramel .

HRN: 21-73-68  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2022
CEFTRIAXONE 1G (VIAL)
08/10/2022
08/16/2022
IVT
2g
Od
Typhoid
Waiting Final Action 
08/12/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/12/2022
08/18/2022
IVT
450mg
Q8
Typhoid Ileitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: